Of course it won't go x20 in the next 6months. But if only one of their clinical trials succeeds and gets approved for commerzialisation in Korea this will go above 10dollar/share (without a single R/S). I am 100% sure of this.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.